Research & Development

Arog Pharmaceuticals, Inc , a privately held, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs to...

PharmAkea Inc. announced the extension of their strategic collaboration with Celgene Corporation which was established to leverage PharmAkea's proprietary drug...

Amgen and Daiichi Sankyo Company announced the execution of an exclusive agreement to commercialize nine biosimilars in Japan. The deal...

AstraZeneca announced that the EC has approved Qtern tablets for the treatment of type 2 diabetes in all 28 EU...

- Approval includes toric version of symfony iol for people with astigmatism- lenses provide high-quality continuous vision so patients can...

• Collaboration aims to develop PROteolysis TArgeting Chimeric molecules (PROTACs) – a new therapeutic modality that is able to degrade...

Abbott announced that Health Canada has approved the company's Absorb bioresorbable heart stent, making the first-of-its-kind medical device commercially available...

Bayer and X-Chem, Inc focused on applying its innovative drug discovery capabilities to the generation of novel small molecule therapeutics,...

AbbVie a global biopharmaceutical company, announced that the U.S. FDA granted Rare Pediatric Disease Designation for ABT-414, an investigational antibody...

Gilead Sciences, Inc announced that the European Commission has granted marketing authorization for Epclusa® (sofosbuvir 400 mg/velpatasvir 100 mg), the...